Dulaglutide, liraglutide and subcutaneous semaglutide have been approved for reducing the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus with established cardiovascular disease, dulaglutide is approved for use in type 2 diabetes mellitus with multiple risk factors, and both liraglutide and semaglutide have been approved for chronic weight management
No surprise charges three months into treatment
Unger, Ketterer, Dupr, Eisentraut
While GLP-1 drugs are not yet FDA-approved specifically for alcohol use disorder, prescribers can discuss off-label use in appropriate clinical contexts
This may push hair follicles into the resting phase, causing increased hair shedding, a condition known as telogen effluvium (TE)
Expect to maintain muscle, not gain significantly, during active weight loss